We are delighted to share that our Founder & CEO, Sandip Patel, will be presenting at the 1st Pitch Life Science office hour hosted by Mid Atlantic Bio Angels on May 20, 2025, at 11 AM ET.
This is a fantastic opportunity for us to highlight our groundbreaking innovations in drug product development and engage with a panel of investors for feedback.
BIOVERIC's programs are investigational product candidates. They have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency, and their safety and effectiveness have not been established.
← All news